Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 29, 2002
Strategies for increasing treatment compliance: the role of long-acting antipsychotics
Raymond C Love
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 15, 2003
Olanzapine and risperidone
Raymond C Love, Deanna L Kelly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 7, 2004
Long-acting risperidone injection
Raymond C Love, Robert J Conley
The Mental Health Clinician
|
March 8, 2019
Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving management
Deanna L Kelly, Raymond C Love
The Mental Health Clinician
|
May 2, 2024
Training student pharmacists to administer long-acting injectable medications
Megan J Ehret, Raymond C Love, Bethany DiPaula
Pharmacotherapy
|
July 30, 2009
Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study
Darren J Freeman, Bethany A DiPaula, Raymond C Love
Psychiatric Services (Washington, D.C.)
|
October 15, 2003
A guide for managing acute aggressive behavior of youths in residential and inpatient treatment facilities
Susan dosReis, Shannon Barnett, Raymond C Love, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 23, 2003
Expert consensus-based medication-use evaluation criteria for atypical antipsychotic drugs
Raymond C Love, Marie Mackowick, Daniel Carpenter, et al.
Psychiatric Services (Washington, D.C.)
|
October 17, 2017
Addressing Barriers to Clozapine Underutilization: A National Effort
Deanna L Kelly, Oliver Freudenreich, MacKenzie A Sayer, et al.
Expert Review of Clinical Pharmacology
|
February 21, 2023
Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues
Jonathan G Leung, Megan Ehret, Raymond C Love, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 29, 2002
Strategies for increasing treatment compliance: the role of long-acting antipsychotics
Raymond C Love
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 15, 2003
Olanzapine and risperidone
Raymond C Love, Deanna L Kelly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 7, 2004
Long-acting risperidone injection
Raymond C Love, Robert J Conley
The Mental Health Clinician
|
March 8, 2019
Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving management
Deanna L Kelly, Raymond C Love
The Mental Health Clinician
|
May 2, 2024
Training student pharmacists to administer long-acting injectable medications
Megan J Ehret, Raymond C Love, Bethany DiPaula
Pharmacotherapy
|
July 30, 2009
Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study
Darren J Freeman, Bethany A DiPaula, Raymond C Love
Psychiatric Services (Washington, D.C.)
|
October 15, 2003
A guide for managing acute aggressive behavior of youths in residential and inpatient treatment facilities
Susan dosReis, Shannon Barnett, Raymond C Love, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 23, 2003
Expert consensus-based medication-use evaluation criteria for atypical antipsychotic drugs
Raymond C Love, Marie Mackowick, Daniel Carpenter, et al.
Psychiatric Services (Washington, D.C.)
|
October 17, 2017
Addressing Barriers to Clozapine Underutilization: A National Effort
Deanna L Kelly, Oliver Freudenreich, MacKenzie A Sayer, et al.
Expert Review of Clinical Pharmacology
|
February 21, 2023
Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues
Jonathan G Leung, Megan Ehret, Raymond C Love, et al.
Page
of 5